Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc (ALNY)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
267. 47
-15.68
-5.5377%
$
37.27B Market Cap
- P/E Ratio
- Div Yield
1.38M Volume
-3.56 Eps
$ 283.15
Previous Close
Add Transaction
Day Range
266.43 284.36
Year Range
266.43 495.55
Want to track ALNY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Alnylam Pharmaceuticals Inc Investors

Name Quantity Cost Value Profit ($) Gain (%)
HFM Investment Advisors LLC
HFM Investment Advisors LLC HFM Investment Advisors LLC
1 $397.7 $272.84 -$124.86 -31.4%
TFI
Towarzystwo Funduszy Inwestycyjnych PZU SA Towarzystwo Funduszy Inwestycyjnych PZU SA
468 $127,912.41 $127,689.12 -$223.29 -0.17%
MKG
Masterinvest Kapitalanlage GmbH Masterinvest Kapitalanlage GmbH
1,179 $390,096 $321,678.36 -$68,417.64 -17.54%
Erik Bonnett
Erik Bonnett Tripletail Wealth Management LLC
10 $4,542 $2,728.4 -$1,813.6 -39.93%
AAI
ABN AMRO Investment Solutions ABN AMRO Investment Solutions
5,767 $2.13M $1.61M -$521,784.61 -24.48%
United Financial Planning Group LLC
United Financial Planning Group LLC United Financial Planning Group LLC
21 $7,215.57 $5,720.4 -$1,495.17 -20.72%
KCS
Kepler Cheuvreux (Suisse) SA Kepler Cheuvreux (Suisse) SA
1,713 $566,779 $481,798.4 -$84,980.6 -14.99%